Product Code: ETC089505 | Publication Date: Jun 2021 | Updated Date: Feb 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
The antiparasitic drugs market in Malaysia was valued at approximately USD 74 million in 2025 and is projected to grow at a CAGR of 8.4% over the forecast period. Increasing awareness about zoonotic diseases among both pet owners and veterinarians as well as favorable government policies regarding animal health safety regulations are major factors expected to contribute towards market growth over the forecast period. In addition, technological advancements such as smart drug delivery systems will have an additional beneficial effect on overall revenue generation within this sector in Malaysia.
The antiparasitic drugs market in Malaysia could be influenced by factors such as the prevalence of parasitic infections, awareness programs on tropical diseases, and the expansion of healthcare facilities. Additionally, changes in climate and environmental conditions might affect the incidence of parasitic diseases.
The antiparasitic drugs market in Malaysia could face challenges such as the prevalence of counterfeit drugs and challenges in accurate diagnosis of parasitic infections. Ensuring accessibility of antiparasitic drugs in remote areas might also be a challenge. Moreover, resistance to existing antiparasitic medications might require the development of new treatment options.
The antiparasitic drugs market in Malaysia experienced fluctuations during the pandemic as the focus on infectious diseases changed. Reduced demand from the veterinary and healthcare sectors impacted the market. Supply chain disruptions and export-import restrictions affected product availability.
The antiparasitic drugs market in Malaysia is supported by pharmaceutical companies offering medications for the treatment of parasitic infections in humans and animals. Key players in Malaysia antiparasitic drugs market may include ParasiticPharma Sdn Bhd, Antiparasitic Solutions, and PharmaParasite Industries. These companies are expected to focus on product efficacy, safety, and meeting the needs of healthcare professionals and veterinarians.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Malaysia Antiparasitics Drugs Market Overview |
3.1 Malaysia Country Macro Economic Indicators |
3.2 Malaysia Antiparasitics Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Malaysia Antiparasitics Drugs Market - Industry Life Cycle |
3.4 Malaysia Antiparasitics Drugs Market - Porter's Five Forces |
3.5 Malaysia Antiparasitics Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.6 Malaysia Antiparasitics Drugs Market Revenues & Volume Share, By Drug class, 2021 & 2031F |
3.7 Malaysia Antiparasitics Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Malaysia Antiparasitics Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Malaysia Antiparasitics Drugs Market Trends |
6 Malaysia Antiparasitics Drugs Market, By Types |
6.1 Malaysia Antiparasitics Drugs Market, By Route of Administration |
6.1.1 Overview and Analysis |
6.1.2 Malaysia Antiparasitics Drugs Market Revenues & Volume, By Route of Administration, 2021-2031F |
6.1.3 Malaysia Antiparasitics Drugs Market Revenues & Volume, By Oral, 2021-2031F |
6.1.4 Malaysia Antiparasitics Drugs Market Revenues & Volume, By Injectable, 2021-2031F |
6.1.5 Malaysia Antiparasitics Drugs Market Revenues & Volume, By Topical, 2021-2031F |
6.2 Malaysia Antiparasitics Drugs Market, By Drug class |
6.2.1 Overview and Analysis |
6.2.2 Malaysia Antiparasitics Drugs Market Revenues & Volume, By Anthelmintics, 2021-2031F |
6.2.3 Malaysia Antiparasitics Drugs Market Revenues & Volume, By Antiprotozoals, 2021-2031F |
6.2.4 Malaysia Antiparasitics Drugs Market Revenues & Volume, By Others, 2021-2031F |
6.3 Malaysia Antiparasitics Drugs Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Malaysia Antiparasitics Drugs Market Revenues & Volume, By Hospital Pharmacies, 2021-2031F |
6.3.3 Malaysia Antiparasitics Drugs Market Revenues & Volume, By Retail Pharmacies, 2021-2031F |
6.3.4 Malaysia Antiparasitics Drugs Market Revenues & Volume, By Online Pharmacies, 2021-2031F |
7 Malaysia Antiparasitics Drugs Market Import-Export Trade Statistics |
7.1 Malaysia Antiparasitics Drugs Market Export to Major Countries |
7.2 Malaysia Antiparasitics Drugs Market Imports from Major Countries |
8 Malaysia Antiparasitics Drugs Market Key Performance Indicators |
9 Malaysia Antiparasitics Drugs Market - Opportunity Assessment |
9.1 Malaysia Antiparasitics Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.2 Malaysia Antiparasitics Drugs Market Opportunity Assessment, By Drug class, 2021 & 2031F |
9.3 Malaysia Antiparasitics Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Malaysia Antiparasitics Drugs Market - Competitive Landscape |
10.1 Malaysia Antiparasitics Drugs Market Revenue Share, By Companies, 2024 |
10.2 Malaysia Antiparasitics Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |